FAM199X expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.110950E-01
Normal-vs-Stage2
4.417200E-01
Normal-vs-Stage3
2.062000E-01
Normal-vs-Stage4
1.453190E-01
Stage1-vs-Stage2
9.124200E-01
Stage1-vs-Stage3
1.164190E-02
Stage1-vs-Stage4
3.020800E-01
Stage2-vs-Stage3
2.822900E-03
Stage2-vs-Stage4
9.370000E-02
Stage3-vs-Stage4
9.087600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.983600E-01
Normal-vs-AfricanAmerican
2.495800E-01
Normal-vs-Asian
4.978200E-01
Caucasian-vs-AfricanAmerican
2.449000E-01
Caucasian-vs-Asian
9.916000E-01
AfricanAmerican-vs-Asian
3.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.714800E-01
Normal-vs-Female
4.678200E-01
Male-vs-Female
8.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.240600E-01
Normal-vs-Age(41-60Yrs)
3.095600E-01
Normal-vs-Age(61-80Yrs)
5.618800E-01
Normal-vs-Age(81-100Yrs)
7.499400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.703400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.427000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.641200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.493800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.147390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.215600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.704800E-01
Normal-vs-Daily Drinker
7.237000E-01
Normal-vs-Weekly Drinker
6.821400E-01
Normal-vs-Occasional Drinker
2.302600E-01
Normal-vs-Social Drinker
4.783000E-01
Non Drinker-vs-Daily Drinker
4.980400E-01
Non Drinker-vs-Weekly Drinker
6.287800E-01
Non Drinker-vs-Occasional Drinker
1.475450E-01
Non Drinker-vs-Social Drinker
9.550800E-01
Daily Drinker-vs-Weekly Drinker
9.189000E-01
Daily Drinker-vs-Occasional Drinker
7.054000E-02
Daily Drinker-vs-Social Drinker
5.445200E-01
Weekly Drinker-vs-Occasional Drinker
1.320950E-01
Weekly Drinker-vs-Social Drinker
6.487400E-01
Occasional Drinker-vs-Social Drinker
2.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.112300E-02
Normal-vs-Grade 2
2.582300E-02
Normal-vs-Grade 3
1.118430E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.652800E-01
Grade 1-vs-Grade 3
4.308200E-02
Grade 1-vs-Grade 4
6.112300E-02
Grade 2-vs-Grade 3
1.853010E-01
Grade 2-vs-Grade 4
2.582300E-02
Grade 3-vs-Grade 4
1.118430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.139400E-01
Normal-vs-NonDiabetic
4.980800E-01
Diabetic-vs-NonDiabetic
2.592000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.588000E-01
Normal-vs-NoPancreatitis
5.359400E-01
Pancreatitis-vs-NoPancreatitis
6.277000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.289200E-01
Normal-vs-N1
4.300600E-01
N0-vs-N1
2.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.734400E-01
Normal-vs-TP53-NonMutant
5.018800E-01
TP53-Mutant-vs-TP53-NonMutant
1.458400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
